Coblopasvir and Sofosbuvir in Patients With HCV Infection Coblopasvir and Sofosbuvir in Patients With HCV Infection
This study investigated the safety and efficacy of coblopasvir plus sofosbuvir in a broad range of HCV infections, including those with compensated cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2020 Category: Surgery Tags: Cardiology News Source Type: news
Researchers create accurate model of organ scarring using stem cells in a lab
Every organ in the body is capable, to some extent, of repairing itself after an injury. As part of this process, scar tissue forms and then recedes to make room for normal tissue when healing is complete.However, when healing is disrupted — whether by chronic injury or disease — the cells that make up scar tissue can go rogue, continuously dividing and spreading until the scar eventually strangles the organ it was intended to help heal, which can lead to organ failure.That progressive, out-of-control scarring is called fibrosis, and it can occur in any organ in the body. Fibrosis plays a major role in many diseases an...
Source: UCLA Newsroom: Health Sciences - December 11, 2019 Category: Universities & Medical Training Source Type: news
Inappropriate Prescriptions Common in Cirrhosis Inappropriate Prescriptions Common in Cirrhosis
Patients with decompensated cirrhosis are not always taking recommended medications, a review of prescription records shows, and some drugs could cause harm.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients
(Medical University of South Carolina) Hepatic encephalopathy (HE) is a reversible complication of liver cirrhosis thought to be caused by ammonia and is typically treated with lactulose. Researchers at the Medical University of South Carolina conducted a cohort study that examined the correlation of ammonia levels with lactulose treatment. They found no correlation between ammonia level and dose of lactulose given. They concluded that ammonia levels are not helpful for clinicians in the management of HE in cirrhotic patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2019 Category: International Medicine & Public Health Source Type: news
